The Recall Desk
ModerateFDA (Devices)·Z-0167-2024·Announced 2023-11-01

Grafton DBM Putty bone matrix implants recalled for packaging defects

Medtronic is recalling Grafton DBM Putty bone matrix implants because the outer Tyvek pouch inspection step may not have been performed, potentially releasing non-conforming batches.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: FDA Class II voluntary recall for a potential manufacturing inspection oversight with no reported incidents or described health risk. The recall is precautionary pending verification that the outer packaging of affected batches meets specifications.

Plain-English summary

Medtronic Sofamor Danek USA Inc is recalling Grafton DBM Putty, a demineralized bone matrix product used in spinal surgery and orthopedic procedures. The affected product includes model numbers T43102, T43102INT, T43103INT, T43105, T43105INT, T43110, and T43110INT.

The recall was initiated because a quality control step for inspecting the outer Tyvek pouch may not have been performed according to requirements, potentially resulting in batches being released with non-conforming outer packaging.

The affected products were distributed across the United States, Colombia, South Korea, New Zealand, India, and Taiwan. Healthcare providers and patients who have received these products should contact Medtronic Sofamor Danek USA Inc for instructions on handling affected units.

The recalled product

Product
Grafton DBM Putty, Model Numbers: a) T43102, b) T43102INT, c) T43103INT, d) T43105, e) T43105INT, f) T43110, g) T43110INT; Demineralized Bone Matrix
Manufacturer
Medtronic Sofamor Danek USA Inc
Hazard
  • packaging-defect
  • sterility-risk

Distribution

Distribution scope not specified by the agency.